Author:
Bauer J.,Clavien P.-A.,Dutkowski P.,Gantert W.A.,Lurje G.,Müllhaupt B.,Renner E.L.,Schmeding M.,Selzner M.,von Flüe M.,Sieber C.
Publisher
Springer Berlin Heidelberg
Reference174 articles.
1. Als-Nielsen B, Gluud LL, Gluud C (2004) Dopaminergic agonists for hepatic encephalopathy. Cochrane Database Syst Rev 18:CD003047
2. Ballet F, Chretien Y, Rey C et al. (1988) Differential response of normal and cirrhotic liver to vasoactive agents. A study in the isolated perfused rat liver. J Pharmacol Exp Ther 244:233–235
3. Blei AT, Cordoba J (2001) Practice Parameters Committee of the American College of Gastroenterology. Hepatic encephalopathy. Am J Gastroenterol 96:1968–1976
4. Butterworth RF (2003) Hepatic encephalopathy – a serious complication of alcoholic liver diesease. Alcohol Res Health 27:143–145
5. Graupera M, Garcia-Pagan JC, Titos E et al. (2002) 5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat liver: a possible role of cysteinyl-leukotrienes. Gastroenterology 122:387–393